Yahoo Finance Site Map
ArticlesFor a comprehensive guide to our content, please see the Site Index
SiteMap 2023 > 10 > 17
Other dates of the month:
- Rolls-Royce to cut up to 2,500 jobs in latest efficiency drive
- UPDATE 4-Rolls-Royce to cut up to 2,500 jobs in latest efficiency drive
- Factbox-China's measures to shore up its indebted property sector
- OKA Corporation Bhd (KLSE:OKA) Is Finding It Tricky To Allocate Its Capital
- Despite the downward trend in earnings at Anglo American (LON:AAL) the stock lifts 6.2%, bringing five-year gains to 82%
- Some Investors May Be Worried About James Fisher and Sons' (LON:FSJ) Returns On Capital
- Japan's Nikkei rebounds as earnings optimism supplants Middle East concerns
- FTX Plans to Return 90% of Customer Funds, But There's a Catch
- UPDATE 12-Brussels gunman who killed two Swedes shot dead by police
- UPDATE 4-Country Garden on brink of default as payment deadline nears
- Flash News: OKX Launches Referral Campaign for the Crypto Cricket Cup with US$200k+ Prize Pool
- A one-two punch for SunPower ahead of slashed solar incentives: 5 big analyst cuts
- Form 8.5 (EPT/RI) - Dechra Pharmaceuticals plc
- Form 8.5 (EPT/RI) - Finsbury Food Group plc
- Form 8.5 (EPT/RI) - Restaurant Group plc
- Rolls-Royce to cut 2,500 jobs
- TSMC Drops Plan for Chip Site After Reports of Local Protest
- 20 Countries with the Cheapest Gas Prices
- DisputeHelp Meeting with EU And US Acquirers for Dispute Management Solutions
- The City confronts the case for slavery reparations
- Invitation to UPM’s webcast and press conference on Q3 2023 Interim report
- Pyridine Market to Hit US$ 2.88 Billion with a CAGR of 7.3% by 2033 : Fact.MR Report
- Tessellate BIO Emerges from Stealth
- Nemysis Limited Covered in Research Note
- Global Animal Parasiticides Market Size, Dynamics: Setting the Stage for USD 18.48 Billion in 2032 with a 6.22% CAGR
- Municipality Finance issues NOK 1 billion notes under its MTN programme
- Park Place Technologies Acquires UK IT Solutions Firm Xuper
- FLSmidth to further boost its service centre network through expansion in Kazakhstan and investment in a new service centre in the US
- Earnings To Watch: Netflix (NFLX) Reports Q3 Results Tomorrow
- New Zealand Energy Announces Proposed Share Consolidation
- UPDATE 2-Umicore cuts net investment target as grants help offset planned spending
- Best Growth Stocks to Buy for October 17th
- LIFT Intersects 37 m at 1.22% Li2O at the Fi Southwest pegmatite and 16 m at 1.24% Li2O at the Fi Main pegmatite, Yellowknife Lithium Project, NWT, Announces Management Update
- Investing in ING Groep (AMS:INGA) three years ago would have delivered you a 143% gain
- Umicore cuts net investment target as grants help offset planned spending
- Monroe County Agriculture: Michigan is a diverse ag state
- Hong Kong Crypto Exchange OSL Weighs Sale at HK$1 Billion Valuation
- Defence's Delivery of Encapsulated AccuTOX(TM)-Chitosan Nanoparticles Triggers Complete Tumor Regression in Animals with Pre-Established Solid Lymphoma
- Lam Research (LRCX) Q1 Earnings: What To Expect
- With EPS Growth And More, Whitbread (LON:WTB) Makes An Interesting Case
- NineDot Energy signs Starbucks as anchor customer for NYC community battery storage
- Global Wearable Heart Monitoring Devices Market Analysis Report 2023: Diagnostic and Monitoring Devices Lead the Market with Multiple Applications - Forecasts to 2032
- Bitcoin's Rising Dominance Rate Challenges Altcoin Boom From 2021
- Electric truck maker Volta Trucks files for bankruptcy in Sweden
- Returns On Capital At Genting Malaysia Berhad (KLSE:GENM) Have Hit The Brakes
- Global $9.66 Bn Vegan Supplements Markets, 2017-2022, 2022-2027F, 2032F: Minerals, Vitamins, Protein, Powder, Liquid, Capsules, Bars
- Alibaba, Tencent Join Funding for Chinese AI High-flyer Baichuan
- Japan ruling LDP offers proposals for Kishida's economic package, but no income tax cuts
- Owning 70% in ViTrox Corporation Berhad (KLSE:VITROX) means that insiders are heavily invested in the company's future
- With $56M, a Mayo Clinic-backed startup takes aim at radiopharmaceutical roadblocks